Submitted by pharmamanufacturing on Fri, 06/20/2008 - 15:54
Karen King, President of DSM Biologics, discussed the implications of the company's recent joint venture with Crucell, which has increased upstream productivity. The technology, PER.C, has reportedly boosted fermentation yields in human cells to over 27 grams/L compared with 15 g/L a few months ago.
Submitted by pharmamanufacturing on Fri, 06/20/2008 - 13:31
One session on Wednesday morning addressed the use of molecular modeling in drug development. Ian Wilson, Portfolio and Strategy Manager, GE Healthcare discussed the development of PET clinical biomarkers. He mentioned the need to collaborate early, and the fact that academic partners can be great partners.
Category: cGxP's FDA and Regulatory Issues Lean Six Sigma and Quality Improvement The Pharma Industry BIO Conference Biotechnology and biopharmaceuticals Wyeth management BIO 2008
Submitted by pharmamanufacturing on Fri, 06/20/2008 - 13:10
Spoke briefly with one, Michael Kowolenko, SVP of biopharmaceutical manufacturing at Wyeth, who talked about the industry’s fear of change, why it exists and offered some suggestions on what to do about it. Below are some (raw) audio snippets of the interview.
Category: The Pharma Industry New Drug Pipeline and R&D Vaccines India China and Asian Pharma BIO Conference BIO 2008 drug development Advinus Therapeutics
Submitted by pharmamanufacturing on Fri, 06/20/2008 - 12:27
Missed Madame Piramal’s presentation, unfortunately, while running back and forth between segments of the building and the show floor. The message behind speakers at the session on Indian Biotech was clear: don’t think “low cost,” think innovation. BMS alumnus Rashmi Barbhaiya used the Nano, India’s new model car, as a metaphor.
Submitted by pharmamanufacturing on Fri, 06/20/2008 - 11:03
Caution. People Crossing.. (San Diego’s only about 40 miles away from the Mexican border. BTW, these are highways that nobody should ever attempt crossing) Best radio station by far– Channel 28 from Baja California, Mexico. AMS
Submitted by pharmamanufacturing on Fri, 06/20/2008 - 11:01
At a session on Wednesday afternoon, Richard Friedman of CDER discussed FDA and foreign inspections of manufacturing sites, and mentioned proposed solutions that would harmonize requirements and lighten the load, while maintaining standards. They include a global system of surveillance and mutual inspectorate acceptance.
Category: BIO 2008
Submitted by pharmamanufacturing on Fri, 06/20/2008 - 10:56
Unfortunately, missed meatier case studies, only to hear motherhood and apple pie presentations about what contract manufacturers need to offer their customers, although Dr. Wiltrud Treffenfeldt, Director of Bioprocess Development, Dow AgroSciences LLC mentioned some innovative German CMOs, including Greenovation and Rentschler as well as Richter-Helen Biologics.
Category: Miscellany Genzyme Pharmaceutical Industry Goodwill and Philanthropy Drug pricing BIO 2008 San Diego drug development Gates Foundation orphan drugs Avant Immunotherapeutics Ltd. Commons Capital
Submitted by pharmamanufacturing on Fri, 06/20/2008 - 10:49
On Tuesday afternoon, a panel discussed ways in which corporations might be able to stimulate the development of more therapies for serious diseases----the world’s top killers such as malaria. The topic is one that I’m very interested, but, unfortunately, I arrived late and missed much of the discussion.
Category: BIO 2008 San Diego Craig Venter Foundation Arnold Schwarzenegger BioGENEius winners stem cell research
Submitted by pharmamanufacturing on Fri, 06/20/2008 - 10:35
Scheduled meetings kept me from the events I’d most wanted to attend: • the live versions of Schwarzenegger’s and Craig Venter’s keynotes (I made it to the tail end of the “overflow” line, where we were treated to lunch and the keynotes on video) • a meeting of former FDA...
Submitted by pharmamanufacturing on Fri, 06/20/2008 - 09:44
OK, this is not coming at the speed of the Internet. Not even close, as BIO 2008 winds down today. But blame an interesting program spread out on a grand scale. Roller skates or a Segway were a must for anyone attempting to navigate BIO 2008 at the San Diego...